A-01
Registration at the conference venue
Tuesday 14:00-18:00 |
A-02
Opening ceremony and welcome reception
Tuesday 19:30-21:00 |
B-01
Registration at the conference venue
Wednesday 08:00-08:45 |
B-02
Welcome and Introduction
Wednesday 08:45-09:00 |
B-03 Nigel Klein
A biological perspective on immune response to drug treatment (intended and unintended effects)
Wednesday 09:00-09:40 |
B-04 Hans Peter Grimm
Intricate PK and PD for the novel immunocytokine CEA-IL2v and their pre-clinical to clinical translation
Wednesday 09:40-10:00 |
B-05 Kirill Peskov
Investigation of anti-CTLA-4 immuno-oncology therapy through a quantitative systems pharmacology model
Wednesday 10:00-10:20 |
B-06
Coffee break, poster and software session I: posters in Group I (with poster numbers starting with I-) are accompanied by their presenter
Wednesday 10:20-11:40 |
B-07 Kapil Gadkar
A Six-Stage Workflow for Robust Application of Systems Pharmacology
Wednesday 11:40-12:00 |
B-08 Rob van Wijk
The zebrafish as model for translational systems pharmacology: expanding the allometric scale in vertebrates with five orders of magnitude
Wednesday 12:00-12:20 |
B-09
Lunch
Wednesday 12:20-13:50 |
B-10 Shasha Jumbe
Introduction to the Gates' Healthy Birth, Growth & Development knowledge integration project
Wednesday 13:50-14:05 |
B-11 Louise Ryan
Trajectory modelling based on early childhood longitudinal growth data
Wednesday 14:05-14:45 |
B-12 Niclas Jonsson
Determinants for physical growth patterns in low- and middle-income countries
Wednesday 14:45-15:05 |
B-13 Nick Holford
Announcement of WCoP 2016
Wednesday 15:05-15:10 |
B-14
Tea break, poster and software session II: posters in Group II (with poster numbers starting with II-) are accompanied by their presenter
Wednesday 15:10-16:40 |
B-15 Mélanie Wilbaux
Characterizing and Forecasting Individual Weight Changes in Term Neonates
Wednesday 16:40-17:00 |
B-16 Nick Holford
Growth and decline of body size and composition – Prediction of the transition from pre-diabetes to Type 2 diabetes in humans
Wednesday 17:00-17:20 |
B-18 Tram Nguyen
The paradox of highly effective sofosbuvir combo therapy despite slow viral decline
Wednesday 17:40-18:00 |
B-19 Rik Schoemaker
Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children
Wednesday 18:00-18:20 |
B-20
Special surprise...
Wednesday 18:30-18:50 |
C-01 Elin Svensson
Bedaquiline's exposure-response relationship revealed through modeling of mycobacterial load
Thursday 08:45-09:10 |
C-02 Solène Desmée
Joint modelling for nonlinear longitudinal PSA kinetics and survival data in metastatic prostate cancer patients
Thursday 09:10-09:35 |
C-03 Stein Schalkwijk
A physiologically-based population pharmacokinetic analysis to assess a lower efavirenz dose of 400 mg once daily in HIV-infected pregnant women.
Thursday 09:35-10:00 |
C-04
Presentation of Lewis Sheiner student session awards
Thursday 10:00-10:05 |
C-05
Coffee break, poster and software session III: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter
Thursday 10:05-11:30 |
C-06 Matts Kågedal
Time-to-Event Modeling of Peripheral Neuropathy – Platform Mega-Analysis of Eight vc-MMAE Antibody-Drug Conjugates (ADCs)
Thursday 11:30-11:50 |
C-07 Lucy Hutchinson
Mixed-effect modelling of transient tumour growth dynamics following anti-angiogenic therapy
Thursday 11:50-12:10 |
C-08 Maria Luisa Sardu
Modelling of classified individual tumor lesions in metastatic colorectal cancer (mCRC) patients using delay differential equations.
Thursday 12:10-12:30 |
C-09
Lunch
Thursday 12:30-13:50 |
C-10 Robert Bauer
An overview of Estimation-Maximization Algorithms Used in Population Analysis Methods
Thursday 13:50-14:35 |
C-11 Brian Corrigan
Announcement of ACoP7
Thursday 14:35-14:40 |
C-12
Tea break, poster and software session IV: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter
Thursday 14:40-16:00 |
C-13 Yevgen Ryeznik
Adaptive dose finding for time-to-event outcomes with adaptive choice of patient number based on response rate
Thursday 16:00-16:20 |
C-14 Sebastian Wicha
A general pharmacodynamic interaction model based on the Bliss Independence criterion
Thursday 16:20-16:40 |
C-15 Martin Fink
Improving priors for human mAb linear PK parameters by using half-lives from pre-clinical studies
Thursday 16:40-17:00 |
C-16 David McDougall
The Impact of Model Selection for Personalised Dosing
Thursday 17:00-17:20 |
C-17
Social event: Buses depart from the Conference Venue at 19:30
Thursday 20:00-01:00 |
D-01 Lutz Harnisch
Modelling and simulation of neurological endpoints (modified Rankin Scale [mRS] and National Institute of Health Stroke Scale [NIHSS]) to aid clinical trial design in intracerebral hemorrhage (ICH)
Friday 09:00-09:20 |
D-02 Oliver Sander
Model-based development of the secukinumab dosing regimen for the treatment of moderate-to-severe chronic plaque psoriasis
Friday 09:20-09:40 |
D-03 Rasmus Juul Kildemoes
Repeated time to event modelling of opioid consumption in postoperative pain
Friday 09:40-10:00 |
D-04 Thu Thuy Nguyen
Limited sampling strategy for a population pharmacokinetic modelling of cocktail of phenotyping drugs
Friday 10:00-10:20 |
D-05
Preview of PAGE2017
Friday 10:20-10:30 |
D-06
Coffee break
Friday 10:30-11:00 |
D-07 Sylvie Retout
How disease modeling and model-based meta-analyses contributed to understanding the path forward after dose discontinuation of a Phase III study in Alzheimer's disease
Friday 11:00-11:20 |
D-08 Marc Vandemeulebroecke
A longitudinal Item Response Theory model to characterize cognition over time in elderly subjects
Friday 11:20-11:40 |
D-09 Simon Buatois
Utilizing the items from the MDS-UPDRS score to increase drug effect detection power in de novo idiopathic Parkinson's disease patients
Friday 11:40-12:00 |
D-10
Closing remarks
Friday 12:00-12:10 |
D-11
Audience input for potential PAGE2017 topics
Friday 12:10-12:30 |
